Rapid molecular identification of mycobacterial species in positive culture isolates using the biochip test

International Journal of Tuberculosis and Lung Disease

Volumn 15, Issue 12, 2011, Pages 1680-1684

  Pang, Y ^a   Zhou, Y ^a   Wang, S ^a   Tan, Y ^b   Yue, J ^c   Zhao, B ^a   Wang, L ^a,e   Zhao, Y ^a,e   Kam, K M ^d  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b Institute of Pulmonary Diseases of Guangzhou Chest Hospital   (China)

^c TONGJI UNIVERSITY   (China)

^d DEPARTMENT OF HEALTH   (Hong Kong)

^e NONE   (China)

Author keywords

Biochip; Mycobacteria; NTM

Indexed keywords

BACTERIAL RNA; RNA 16S;

ACCURACY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BIOCHIP; MYCOBACTERIUM; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM AURUM; MYCOBACTERIUM AVIUM; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM GILVUM; MYCOBACTERIUM GORDONAE; MYCOBACTERIUM INTRACELLULARE; MYCOBACTERIUM KANSASII; MYCOBACTERIUM MALMAENSE; MYCOBACTERIUM MARINUM; MYCOBACTERIUM MONOCANSE; MYCOBACTERIUM NONCHROMOGENICUM; MYCOBACTERIUM PARASCROFULACEUM; MYCOBACTERIUM PHLEI; MYCOBACTERIUM SCROFULACEUM; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM SZULGAI; MYCOBACTERIUM TERRAE; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM ULCERANS; MYCOBACTERIUM XENOPEI; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPRODUCIBILITY; RNA SEQUENCE; SENSITIVITY AND SPECIFICITY; SPECIES IDENTIFICATION;

EID: 81455138217     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0061     Document Type: Article

References (29)

1. Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organization. 1991. Bull World Health Organ 2001; 79: 71-75.
2. Gopinath K, Singh S. Non-tuberculous mycobacteria in TB-endemic countries: are we neglecting the danger? PLoS Negl Trop Dis 2010; 4: e615.
3. Field S K, Cowie R L. Lung disease due to the more common non-tuberculous mycobacteria. Chest 2006; 129: 1653-1672. (Pubitemid 43894999)
4. Fowler S J, French J, Screaton N J, et al. Non-tuberculous mycobacteria in bronchiectasis: prevalence and patient characteristics. Eur Respir J 2006; 28: 1204-1210. (Pubitemid 44883857)
5. Glassroth J. Pulmonary disease due to non-tuberculous mycobacteria. Chest 2008; 133: 243-251.
6. Zhu L, Jiang G, Wang S, et al. Biochip system for rapid and accurate identification of mycobacterial species from isolates and sputum. J Clin Microbiol 2010; 48: 3654-3660.
7. Primm T P, Lucero C A, Falkinham J O III. Health impacts of environmental mycobacteria. Clin Microbiol Rev 2004; 17: 98-106. (Pubitemid 38120931)
8. Winthrop K L, Chang E, Yamashita S, Iademarco M F, LoBue P A. Non-tuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy. Emerg Infect Dis 2009; 15: 1556-1561.
9. Andrejak C, Thomsen V O, Johansen I S, et al. Non-tuberculous pulmonary mycobacteriosis in Denmark: incidence and prognostic factors. Am J Respir Crit Care Med 2010; 181: 514-521.
10. van Ingen J, Boeree M J, de Lange W C, Dekhuijzen P N, van Soolingen D. Impact of new American Thoracic Society diagnostic criteria on management of nontuberculous mycobacterial infection. Am J Respir Crit Care Med 2007; 176: 418; author reply 9.
11. Griffith D E, Aksamit T, Brown-Elliott B A, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of non-tuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175: 367-416.
12. Billinger M E, Olivier K N, Viboud C, et al. Non-tuberculous mycobacteria-associated lung disease in hospitalized persons, United States, 1998-2005. Emerg Infect Dis 2009; 15: 1562-1569.
13. McGrath E E, Anderson P B. The therapeutic approach to non-tuberculous mycobacterial infection of the lung. Pulm Pharmacol Ther 2010; 23: 389-396.
14. Wu T S, Leu H S, Chiu C H, et al. Clinical manifestations, antibiotic susceptibility and molecular analysis of Mycobacterium kansasii isolates from a university hospital in Taiwan. J Antimicrob Chemother 2009; 64: 511-514.
15. Somoskovi A, Mester J, Hale Y M, Parsons L M, Salfinger M. Laboratory diagnosis of non-tuberculous mycobacteria. Clin Chest Med 2002; 23: 585-597.
16. Cloud J L, Carroll K C, Cohen S, Anderson C M, Woods G L. Interpretive criteria for use of AccuProbe for identification of Mycobacterium avium complex directly from 7H9 broth cultures. J Clin Microbiol 2005; 43: 3474-3478. (Pubitemid 40981370)
17. Park H, Jang H, Song E, et al. Detection and genotyping of Mycobacterium species from clinical isolates and specimens by oligonucleotide array. J Clin Microbiol 2005; 43: 1782-1788.
18. Ruiz P, Gutierrez J, Zerolo F J, Casal M. GenoType mycobacterium assay for identification of mycobacterial species isolated from human clinical samples by using liquid medium. J Clin Microbiol 2002; 40: 3076-3078. (Pubitemid 35284995)
19. Tortoli E, Mariottini A, Mazzarelli G. Evaluation of INNOLiPA MYCOBACTERIA v2: improved reverse hybridization multiple DNA probe assay for mycobacterial identification. J Clin Microbiol 2003; 41: 4418-4420. (Pubitemid 37099719)
20. Wong D A, Yip P C, Tse D L, Tung V W, Cheung D T, Kam K M. Routine use of a simple low-cost genotypic assay for the identification of mycobacteria in a high throughput laboratory. Diagn Microbiol Infect Dis 2003; 47: 421-426. (Pubitemid 38373414)
21. Freidlin P J, Goldblatt D, Kaidar-Shwartz H, Rorman E. Polymorphic exact tandem repeat A (PETRA): a newly defined lineage of Mycobacterium tuberculosis in Israel originating predominantly in sub-Saharan Africa. J Clin Microbiol 2009; 47: 4006-4020.
22. Burggraf S, Reischl U, Malik N, Bollwein M, Naumann L, Olgemoller B. Comparison of an internally controlled, large-volume LightCycler assay for detection of Mycobacterium tuberculosis in clinical samples with the COBAS AMPLICOR assay. J Clin Microbiol 2005; 43: 1564-1569.
23. Koh W J, Kwon O J, Lee K S. Diagnosis and treatment of non-tuberculous mycobacterial pulmonary diseases: a Korean perspective. J Korean Med Sci 2005; 20: 913-925. (Pubitemid 43161852)
24. Stout J E. Evaluation and management of patients with pulmonary nontuberculous mycobacterial infections. Expert Rev Anti Infect Ther 2006; 4: 981-993. (Pubitemid 46040351)
25. Cloud J L, Neal H, Rosenberry R, et al. Identification of Mycobacterium spp. by using a commercial 16S ribosomal DNA sequencing kit and additional sequencing libraries. J Clin Microbiol 2002; 40: 400-406. (Pubitemid 34130860)
26. Soini H, Musser J M. Molecular diagnosis of mycobacteria. Clin Chem 2001; 47: 809-814. (Pubitemid 32398030)
27. Williams K J, Ling C L, Jenkins C, Gillespie S H, McHugh T D. A paradigm for the molecular identification of Mycobacterium species in a routine diagnostic laboratory. J Med Microbiol 2007; 56: 598-602. (Pubitemid 46717481)
28. Hillemann D, Rüsch-Gerdes S, Richter E. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol 2007; 45: 2635-2640. (Pubitemid 47295497)
29. Washington L, Miller W T Jr. Mycobacterial infection in immuno compromised patients. J Thorac Imaging 1998; 13: 271-281. (Pubitemid 28492985)